Gamekeeper turned Poacher

Preparing you for your Inspection

Many of you might know me as an MHRA Senior GDP inspector, well not anymore. I left the MHRA in January 2022 to join SeerPharmaUK as a trainer and consultant. Am I really a ‘gamekeeper’ turned ‘poacher’? I shall leave you to decide. What I do want to do is help you understand the best way to approach an MHRA inspection – to get the most out of it, to demonstrate what you do well and, most of all, to demonstrate a commitment to public safety.

You receive the MHRA letter informing you of an inspection date…. What now?
Preparing for the day when an inspector attends the site can be daunting for all staff, not just the Responsible Person or Licence Holder.

I have heard so often that a company works on an ‘audit-ready’ basis.

So, what is an ‘audit-ready’ basis? It means using your quality tools to see how well your systems, processes and documentation are working and to assess and influence quality in your organisation. It helps you identify the gaps before an inspector finds them; however when you receive the MHRA notification you are likely to feel quite anxious and wonder if all the hard work you continually put in will adequately fulfil the requirements of an inspector.

How best to prepare

Interpreting what the MHRA inspector requires is not always an easy task. For example, what the pharmaceutical professional sees as suitable may not always correspond with what the inspector sees as suitable. This can often be confusing and daunting, particularly when a significant amount of work has already been put into writing and implementing the QMS, training and other key quality processes.

Interpreting questions and what the expected answer should be can sometimes be confusing. If there is ambiguity, ask the inspector to clarify the question, or ask them to explain it differently. This is very important, and indeed, you must ask for clarification if you do not fully understand what the inspector is requesting.

  • Be honest and open
  • Show what the risks are to your supply chain
  • What current control measures are in place?
  • Define processes and procedures in the quality management system
  • Ensure staff are fully trained (ongoing) and competency training conducted

The inspector is attending to ensure you are complying with your regulatory obligation in protecting patient safety and ensuring product quality is maintained throughout the supply chain. Remember they are not there to advise or recommend.

Both the RP and the inspector have a common purpose and that is to protect patient safety and maintain product quality.

What not to ask an inspector

Am I doing it right?
Can you advise me?
Is there sufficient/adequate information in my procedures?

The inspector needs to feel confident that you understand your business model and can demonstrate your understanding of the regulations and GDP is carried out effectively. You will be expected to know you have identified, accessed, mitigated, and communicated risks. Demonstrating RP full oversight, understanding and control is fundamental in providing the inspector with assurances these obligations are being fulfilled.

What did I see as an inspector?

As an inspector, I was often incredibly impressed by the hard work and commitment of RPs, licence holders and their teams. However, all too often, companies can get bogged down in the desire to create systems that can be over-complicated. This includes producing risk assessments that fail to consider causal factors, written procedures that did not reflect the business model or work instructions that didn’t link to the correct procedure. Creating complex systems can be challenging to implement and difficult for staff to be engaged with, particularly when faced with operational factors that can impact on the day job, such as system failures, vehicle breakdown, inclement weather, shortages of medicines, increased stock holding, staff shortages etc etc.

Many RPs are extremely conscientious and want to ensure patient safety and product quality is at the forefront of the business ethos and strive in their role to ensure compliance is controlled and maintained and staff have a thorough understanding of their own roles. Having processes and systems that are overly complex can sometimes be more detrimental to providing assurances to the regulator that complete control is in place and that staff fully understand what is expected of them. Failure to recognise this could have an impact on the organisation’s outcome of an inspection.

So how can you simplify things?

Take a step back and ask yourself, what skillset do we have in our organisation? What benefits can we draw from identifying other areas of expertise in our existing team? For example, when I first became an inspector with the MHRA, I was also qualified in Health & Safety. The skills acquired in my previous employment allowed me to understand risk management and its underlying principles. This provided me with the opportunity to use this knowledge in my role as an inspector, albeit there were other areas of being an inspector where I had to undergo a significant amount of training.

One of the first things to do is identify what technical knowledge your staff have. Overlooking fundamental skillsets in your own organisation may mean your greatest asset is sitting right there and you are unaware!

Ask staff what they think. Is this operating procedure too ambiguous? Are we doing what the work instruction tells us to do? Can we use pictorial training methods alongside written processes? Are we working efficiently and effectively? As an RP, have you considered bouncing ideas off other RPs who you might have met during training?

Knowledge is gained in several ways.

School, college, university, carrying out your daily role, training sessions, listening to webinars, attending seminars. We often overlook the type of training we attend and forget to record it or, when we attend such events, we forget to disseminate it to those who would benefit within the business. Information sharing is vital not only to promoting and safeguarding medicinal product, but it also empowers and increases team morale and provides colleagues with a sense of responsibility.

From regulatory inspector to director

The transition from an MHRA regulatory inspector to a Director of SeerPharmaUK and a trainer in the training team is providing me with the opportunity to work in an environment with skilled and talented individuals who share the same passion – helping those who want to get it right and sharing the wealth of knowledge from 25 years working in industry and as a senior regulatory inspector.

Ask advice of people who know

SeerPharmaUK can provide guidance, encouragement and training. We can harness your existing knowledge, develop it to maximise your understanding of regulatory requirements and provide guidance on the expectations of the inspector. Simply having a chat sometimes helps to sort out ambiguity.

Trainers/consultants can provide a useful distance from the challenges of your business; they are not emotionally invested in operations in the same way that business owners are, and they can more easily identify and address challenges, whether the issue is implementing a new quality system or clarifying regulatory requirements.

A consultation with us can afford the freedom to bring knowledge and experience to the table, to be impartial yet observational (a fresh pair of eyes), have an open discussion on perhaps some of the weaker areas of the business and identify the stronger areas.

Sharing information through training is fundamental to all stakeholders. Many companies want to get it right and many do. However, some need that extra advice, guidance, training, and a suitable strategy to gain the recognition they so clearly deserve.

Remember, the inspector wants the same as you; both of you are working towards the same outcome.

The SeerPharmaUK Team – What makes us different?

The diversity of the directors in the SeerPharmaUK team is unique. My SeerPharmaUK colleagues and I have met a lot of people through our interactions and networking.
We have an extensive pool of skills with a breadth of experience in industry, regulatory, training and consultancy and we can help support you.

We have had the unique opportunity of seeing this from both sides of the fence, which has been enlightening, interesting and insightful. We see some very high industry standards, but we also see a lot of RPs working in isolation- something I often didn’t see as an inspector. When working in isolation, it can be difficult to assess if you’re on the right track or fully complying with your duties, wanting to get it right, but not confidently knowing if you are. We have the knowledge & skillset at our fingertips and can provide the help and guidance to confirm you are on the right path. Considering my own industry experience, I wish there had been an organisation such as SeerPharmaUK out there to help us.

Do I feel like gamekeeper turned poacher? No I don’t. I believe we can all work together to achieve the same outcome and good training, guidance and an ear to listen can make all the difference.

So, in anticipating an inspection, preparation is key. Taking time to consider what training may be required well before the MHRA letter drops through the door, will lessen the impact, and make the inspection a more relaxed experience. The SeerPharmaUK team are here to help you.

If you would like a chat, please contact us.

Nuala Calnan PhD biography

Nuala is a 25 year veteran of the pharmaceutical industry. Her work as a consultant, academic, author and commentator is directed toward the development of practical, patient-focused excellence and includes research for FDA(USA) and HPRA(Ireland) on risk surveillance, patient safety and product quality in themanufacture and distribution of drugs.

Nuala works with organizations on transforming organizational culture, delivering more effective end-to-endproactive risk management, implementing knowledge excellence strategies, behavior-based qualityexcellence and enhancing performance management through people. She is the founder of the Quality Risk

Management Institute and is currently the Co-Ordinator for the Operational Excellence Team at the Institute of Production & Supply Chain Management at St. Gallen University.

Nuala co-leads the ISPE Cultural Excellence Team, acted as Technical Author on the AdvancingPharmaceutical Quality (APQ) Guide series. At TU Dublin, Ireland, Nuala leads a number of patient focusedregulatory science research projects at Masters and PhD level and teaches on the Executive MBA (LifeSciences) on OPEX, QRM and Regulatory Science.

Professor Amira Guirguis biography

Professor Amira Guirguis is the Chief Scientist at the Royal College of Pharmacy and Professor of Pharmacy at Swansea University. A pharmacist independent prescriber, researcher and scientific leader, she works at the interface of pharmacy practice, medicines safety, research, regulation and public policy.

She is internationally recognised for her work in substance misuse, novel and emerging drugs, pharmacovigilance, harm reduction and pharmaceutical science, and has authored more than 100 scientific publications.

Amira has also pioneered the UK’s first Home Office-licensed pharmacist-led drug-checking service.

Alongside her RCPharm leadership role, Amira serves on the UK Government’s Advisory Council on the Misuse of Drugs, the General Pharmaceutical Council’s Fitness to Practise Committee, and the Pharmaceutical Society of Ireland’s Accreditation Panel.

As Chief Scientist, she leads RCPharm’s work to strengthen science and research across the profession and ensure robust evidence informs pharmacy practice, policy and innovation. Her current interests include pharmacovigilance, netnography, diversion of pharmaceuticals, and the opportunities and emerging risks associated with rapidly evolving medicines and therapeutic technologies.

Carolina Luna biography

Carolina Luna is Quality Manager and Responsible Person UK & NL at AIT Worldwide Logistics. With a career spanning pharmaceutical logistics, manufacturing and food production, she brings broad experience of applying GMP and GDP principles across regulated environments. Carolina holds a bachelor’s degree in Agro-Industrial Engineering, specialising in Food Processing.

Throughout her career, Carolina has focused on turning regulatory requirements into quality systems that work in practice. Her achievements include integrating three separate quality management systems into one, leading applications for WDA, API and MIA licences, and transitioning a paper-based QMS to an electronic platform. She has also supported regulatory inspections, conducted supplier audits, developed quality KPIs and delivered GMP/GDP training.

Carolina is currently completing a Level 4 AI and Automation Practitioner qualification and exploring practical applications of AI within pharmaceutical quality management. Through her presentation, “Practical AI for Quality and Compliance”, she aims to give quality professionals the confidence to use AI in a practical and controlled way, while reinforcing that technology should support, rather than replace, professional judgement and human oversight.

Harry Hughes biography

Harry Hughes is UK Ambassador for TAPA EMEA and Managing Director of FET Logistics Ltd. He has nearly 30 years’ experience in logistics and supply chains, specialising in secure, GDP-compliant pharmaceutical transport. His work spans quality systems, cargo crime prevention and supply chain resilience.

Stuart Tatters biography

With over 20 years in logistics, freight forwarding, and time-critical supply chains, Stuart Tatters has learned firsthand how crucial it is to know where your assets are, and where they’re going, at any given moment. In fast-moving, high-stakes environments, visibility isn’t a luxury, it’s a necessity.

That experience shapes everything he does at Sensos, where he helps organisations turn complex supply chains into responsive, efficient ecosystems through end-to-end visibility, AI-powered analytics, and smarter execution. His approach comes down to aligning people, technology, and systems; because when those three work together, you get more than a functional supply chain, you get a competitive advantage.

 

Titus Rawlins bography

A former Royal Navy Ship’s Navigator and Diver, Titus is an airline pilot of 25 years’ experience and a Human Factors Instructor who specialises in training teams who need to perform in hazardous work environments. He is qualified to deliver regulatory training to Flight Crews by the European Union Aviation Safety Administration and both the UK’s Military and Civil Aviation Authorities. 

Presenting to high performance groups and industries as diverse as Medicine and Logistics, from the UK, Europe and as far afield as Qatar and Nigeria, Titus employs a dynamic and interactive style to deliver easily relatable training models and case examples. His sessions have been proven to enhance communication and decision making, thereby minimising risk while improving efficiency, effectiveness and safety. 

Mikael Ginai biography

Mikael Ginai is Sales Director at Ginai Pharmaceuticals, helping drive a new generation of pharmaceutical wholesale.

Combining commercial leadership with a passion for technology and innovation, he has helped lead the development of Ginai’s own in-house ERP system and introduced smarter, more efficient ways of working.

His focus is on building upon the strong foundations of the pharmaceutical industry while embracing technology, innovation and new ideas to help shape its future.